-
Clinical application of genomics- and phosphoproteomics-based selection of targeted therapy in patients with advanced solid tumors
van der Wijngaart, H., 15 Dec 2023, 204 p.Research output: PhD Thesis › Phd-Thesis - Research and graduation internal
-
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
van der Wijngaart, H., Beekhof, R., Knol, J. C., Henneman, A. A., de Goeij-de Haas, R., Piersma, S. R., Pham, T. V., Jimenez, C. R., Verheul, H. M. W. & Labots, M., 1 Dec 2023, In: Clinical Proteomics. 20, 1, 49.Research output: Contribution to journal › Article › Academic › peer-review
-
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Geurts, B. S., Battaglia, T. W., van Berge Henegouwen, J. M., Zeverijn, L. J., de Wit, G. F., Hoes, L. R., van der Wijngaart, H., van der Noort, V., Roepman, P., de Leng, W. W. J., Jansen, A. M. L., Opdam, F. L., de Jonge, M. J. A., Cirkel, G. A., Labots, M., Hoeben, A., Kerver, E. D., Bins, A. D., Erdkamp, F. G. L., van Rooijen, J. M., & 6 others , 1 Dec 2023, In: BMC Cancer. 23, 1, 205.Research output: Contribution to journal › Article › Academic › peer-review
- All publications